Evaluation of Seven Different Brands of Metformin Hydrochloride Tablets Available in the Market in Gondar City, Ethiopia

References

• Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240–249. doi:10.1016/S0140-6736(08)61762-6
   PubMed Web of Science ®Google Scholar
• Butt MD, Ong SC, Wahab MU, et al. Cost of Illness Analysis of Type 2 Diabetes Mellitus: the Findings from a Lower-Middle Income Country. Int J Environ Res Public Health. 2022;19(19):12611. doi:10.3390/ijerph191912611
   PubMed Web of Science ®Google Scholar
• Witter S, Zou G, Diaconu K, et al. Opportunities and challenges for delivering non-communicable disease management and services in fragile and post-conflict settings: perceptions of policy-makers and health providers in Sierra Leone. Confl Health. 2020;14:1–14. doi:10.1186/s13031-019-0248-3
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products; 2017.
   Google Scholar
• Montori VM, Gafni A, Charles C. A shared treatment decision‐making approach between patients with chronic conditions and their clinicians: the case of diabetes. Health Expect. 2006;9(1):25–36. doi:10.1111/j.1369-7625.2006.00359.x
   PubMed Web of Science ®Google Scholar
• Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology. 2005;42(5):987–1000. doi:10.1002/hep.20920
   PubMed Web of Science ®Google Scholar
• Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabet Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Setter SM, Iltz JL, Thams J, Campbell RK. Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy. Clin Ther. 2003;25(12):2991–3026.
   PubMed Web of Science ®Google Scholar
• Bosi E. Metformin–the gold standard in type 2 diabetes: what does the evidence tell us? Diabetes Obes Metab. 2009;11:3–8. doi:10.1111/j.1463-1326.2008.01031.x
   PubMed Web of Science ®Google Scholar
• Boldhane SP, Kuchekar BS. Gastroretentive drug delivery of metformin hydrochloride: formulation and in vitro evaluation using 32 full factorial design. Curr Drug Deliv. 2009;6(5):477–485. doi:10.2174/156720109789941641
   PubMedGoogle Scholar
• Metry M, Shu Y, Abrahamsson B, et al. Biowaiver monographs for immediate release solid oral dosage forms: metformin hydrochloride. J Pharm Sci. 2021;110(4):1513–1526. doi:10.1016/j.xphs.2021.01.011
   PubMed Web of Science ®Google Scholar
• Kaufman B, Novack GD. Compliance issues in manufacturing of drugs. Ocul Surf. 2003;1(2):80–85. doi:10.1016/S1542-0124(12)70131-3
   PubMedGoogle Scholar
• Mackey TK, Liang BA. The global counterfeit drug trade: patient safety and public health risks. J Pharm Sci. 2011;100(11):4571–4579. doi:10.1002/jps.22679
   PubMed Web of Science ®Google Scholar
• Caudron J, Ford N, Henkens M, Macé C, Kiddle‐Monroe R, Pinel J. Substandard medicines in resource‐poor settings: a problem that can no longer be ignored. Trop Med Int Health. 2008;13(8):1062–1072. doi:10.1111/j.1365-3156.2008.02106.x
   PubMed Web of Science ®Google Scholar
• Ozawa S, Evans DR, Bessias S, et al. Prevalence and estimated economic burden of substandard and falsified medicines in low-and middle-income countries: a systematic review and meta-analysis. JAMA Network Open. 2018;1(4):e181662–e181662. doi:10.1001/jamanetworkopen.2018.1662
   PubMed Web of Science ®Google Scholar
• Ajala T, Adebona A, Bamiro O. The pharmaceutical quality of brands of metformin tablets in Ogun-State, Nigeria. Afr J Biomed Res. 2014;17(1):43–48.
   Google Scholar
• Sougi A, Ofori-Kwakye K, Kuntworbe N, Kipo S, Boakye-Gyasi M. Evaluation of the physicochemical and in vitro dissolution properties of metformin hydrochloride tablet brands marketed in five cities in Ghana. Br J Pharm Res. 2016;9(1):1–14. doi:10.9734/BJPR/2016/21862
   Google Scholar
• Kariuki EM, Thoith GN. Quality of Metformin Tablet Products in the Kenyan Market. East Cent Afr J Pharm Sci. 2021;24(2):85–89.
   Google Scholar
• Odeniran OA, Olayemi OJ, Galadima IH, Kirim RA, Isimi CY, Mustapha KB. Quality assessment of nine brands of metformin hydrochloride tablets marketed in Abuja, Nigeria. J Pharm Bioresour. 2021;18(3):216–222. doi:10.4314/jpb.v18i3.6
   Google Scholar
• Eraga SO, Idemili CD, Iwuagwu MA. Pharmaceutical Quality Assessment of Brands of Metformin Hydrochloride Tablets Available in South-East Nigeria. Afr J Pharm Res Dev. 2020;12(3):333–341.
   Google Scholar
• Arora A, Parle A, Dahiya M, Rani R. Comparative evaluation of Metformin tablets available under government supply and brands available in open market in Delhi, India. IOSR J Pharm. 2021;11(5):8–20.
   Google Scholar
• Prithi IJ, Chowdhury SF, Chowdhury S. Comparative in vitro dissolution test and other physicochemical parameters of some commercially available metformin HCl brands in Bangladesh. Pharma Innov. 2018;7(6):5–8.
   Google Scholar
• Tesfay K, Kahsay G, Dinda S. In Vitro Quality Evaluation of Metformin Hydrochloride Tablets Marketed in Western and North Western Tigray, Ethiopia. Austin J Anal Pharm Chem. 2019;6(2):1119.
   Google Scholar
• Abushaheen MA, Fatani AJ, Alosaimi M, et al. Antimicrobial resistance, mechanisms and its clinical significance. Dis Mon. 2020;66(6):100971. doi:10.1016/j.disamonth.2020.100971
   PubMed Web of Science ®Google Scholar
• Marucheck A, Greis N, Mena C, Cai L. Product safety and security in the global supply chain: issues, challenges and research opportunities. J Oper Manag. 2011;29(7–8).
   Web of Science ®Google Scholar
• Newton PN, Lee SJ, Goodman C, et al. Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med. 2009;6(3):e1000052. doi:10.1371/journal.pmed.1000052
   PubMed Web of Science ®Google Scholar
• Stationery Office. British Pharmacopoeia 2013: Published on the Recommendation of the Commission on Human Medicines Pursuant to the Medicines Act 1968 and Notified in Draft to the European Commission in Accordance with Directive 98/34/EEC. London: Stationery Office; 2012.
   Google Scholar
• Hani U, Alhamhoom Y, Alqahtani A, et al. In-vitro Comparative Study of Different Brands of Metoclopramide Hydrochloride Tablets Marketed in Saudi Arabia. Curr Drug Ther. 2020;15(5):512–517. doi:10.2174/1574885515666200305101840
   Web of Science ®Google Scholar
• Hamdan II, Jaber AKB. Pharmaceutical evaluation of metformin HCl products available in the Jordanian market. Jordan J Pharm Sci. 2010;3(22):1–7.
   Google Scholar
• Peck GE, Baley GJ, McCurdy VE, Banker GS. Tablet formulation and design. Pharm Dos Forms Marcel Dekker N Y. 1989;75–130.
   Google Scholar
• Aulton ME. Pharmaceutics: the science of dosage form design. Royal Soc Chem. 2002.
   Google Scholar
• Allen L, Ansel HC. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems. Lippincott Williams & Wilkins; 2013.
   Google Scholar
• Olusola AM, Adekoya AI, Olanrewaju OJ. Comparative evaluation of physicochemical properties of some commercially available brands of metformin HCl tablets in Lagos, Nigeria. J Appl Pharm Sci. 2012;41–44.
   Google Scholar
• Osman Z, Osman A, Abedelghayoum A. Comparative evaluation of physicochemical properties of some commercially available brands of metformin HCl tablets marketed in Sudan. IAJPR. 2017;7:7471–7477.
   Google Scholar
• Vandevivere L, Denduyver P, Portier C, et al. The effect of binder types on the breakage and drying behavior of granules in a semi-continuous fluid bed dryer after twin screw wet granulation. Int J Pharm. 2022;614:121449. doi:10.1016/j.ijpharm.2022.121449
   PubMedGoogle Scholar
• Long M, Chen Y. Dissolution testing of solid products. Developing Solid Oral Dosage Forms Elsevier. 2009;319–340.
   Google Scholar
• Kataoka M, Yano K, Hamatsu Y, Masaoka Y, Sakuma S, Yamashita S. Assessment of absorption potential of poorly water-soluble drugs by using the dissolution/permeation system. Eur J Pharm Biopharm. 2013;85(3):1317–1324. doi:10.1016/j.ejpb.2013.06.018
   PubMed Web of Science ®Google Scholar
• Elghnimi T, Bzezi W, Siaan M, Elgreew W, Benmansour H. Comparative in-vitro Evaluation of Some Commercial Brands of Metformin Tablets Marketed in Tripoli-Libya. Eur J Bio Pharm Sci. 2019;6(6):138–143.
   Google Scholar
• Allen LV Jr. Dosage form design and development. Clin Ther. 2008;30(11):2102–2111. doi:10.1016/j.clinthera.2008.11.015
   PubMed Web of Science ®Google Scholar
• Kottke MJ, Rudnic EM. Tablet dosage forms. In: Modern Pharmaceutics, Fourth Edition Revised and Expanded. CRC Press; 1996:458–532.
   Google Scholar